Concepedia

A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE

Wenjia Zhu, Ru Jia, Qiao Yang, Yuejuan Cheng, Hong Zhao, Chunmei Bai, Jianming Xu, Shaobo Yao, Li Huo

European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 35 citations · 15 references

DOI

Concepts

References

15

Radiolabeled somatostatin receptor antagonists are preferable to agonists for<i>in vivo</i>peptide receptor targeting of tumors

Mihaela Ginj, Hanwen Zhang, Beatrice Waser et al. · Proceedings of the National Academy of Sciences · 2006 · 488 citations · Full text

, , +22

Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study

Damian Wild, Melpomeni Fani, Richard Fischer et al. · Journal of Nuclear Medicine · 2014 · 255 citations · Full text

PET of Somatostatin Receptor–Positive Tumors Using <sup>64</sup>Cu- and <sup>68</sup>Ga-Somatostatin Antagonists: The Chelate Makes the Difference

Melpomeni Fani, Luigi Del Pozzo, K. Abiraj et al. · Journal of Nuclear Medicine · 2011 · 255 citations

Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.

Renzo Cescato, Stefan Schulz, Beatrice Waser et al. · PubMed · 2006 · 185 citations

First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible

Damian Wild, Melpomeni Fani, Martin Béhé et al. · Journal of Nuclear Medicine · 2011 · 178 citations · Full text